BioHealth News
REGENXBIO Announces NAV® Technology Platform Will Support Bespoke Gene Therapy Consortium’s First Rare Disease Clinical Portfolio
ROCKVILLE, Md., May 16, 2023 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that preclinical research in Mucopolysaccharidosis type IVA (MPS IVA), also known…
Read More
Role of global public sector research in discovering new drugs and vaccines
Analysis of international public-sector contributions to Food and Drug Administration (FDA)-approved drugs and vaccines allows for a more thorough examination of the global biomedical…
Read More
President Biden Announces Intent to Nominate Dr. Monica Bertagnolli as Director of the National Institutes of Health
Today (May 15, 2023), President Biden announced his intent to nominate Dr. Monica Bertagnolli as Director of the National Institutes of Health (NIH), the…
Read More
BHI/NIH EIR Anna Zornosa Moderates Panel of Experts: Unlocking Reimbursement for Innovators in Maternal Health Solutions
Reimbursement is key to the success of innovators who have products, therapies, and new modes of service for expectant and new mothers. Not only…
Read More
BHI’s EIR Ethel Rubin, Ph.D., Joins JLABS @ NYC Roundtable
Ethel Rubin, Ph.D., an Entrepreneur-in-Residence at BioHealth Innovation, Inc. (BHI), recently participated in a “CEO Roundtable” for JLABS @ NYC. The discussion revolved around…
Read More
BHI EIR Renée JG Arnold Shares Expertise at the 28th Annual International ISPOR Meeting
Renée JG Arnold, PharmD, RPh, who serves as an Entrepreneur-in-Residence at BHI NHLBI EIR, recently moderated and participated in a panel discussion at the…
Read More
Women In Bio announces appointment of Gina Ford as Executive Director
Women In Bio is proud to announce that Gina Ford has joined our team as Executive Director. Gina brings a wealth of experience, having worked in…
Read More
Join AURP in Boston for a Deep Dive into Building Communities of “Biotech Innovation”!
Join AURP in Boston for a Deep Dive into Building Communities of Biotech Innovation! Before the 2023 BIO International Conference begins in Boston, the…
Read More
Navigating the Challenges of Rare Disease Research with Dr. Harsha Rajasimha on BioTalk
Join us for an enlightening episode of BioTalk with Rich Bendis as we explore the pivotal role of patient registries in rare disease research…
Read More
Raising Awareness: Indo US Bridging RARE Summit 2023 to Shine a Spotlight on Rare Diseases
Scheduled for October 29-30, 2023, at the George Mason University Campus in Arlington, VA, the Indo US Bridging RARE Summit 2023 aims to unite…
Read More
Rockville’s MaximBio Inks Contract with National Institutes of Health (RADx) Centered on a new Rapid Platform
ROCKVILLE, Md. , May 9, 2023 /PRNewswire/ -- MaximBio® is proud to announce it has signed a new agreement with the National Institutes of Health (NIH) through the Rapid Acceleration…
Read More
TEDCO Announces Investment into Rise Therapeutics
Biotech company receives follow-on funding to accelerate ongoing clinical development efforts COLUMBIA, Md. (May 8, 2023) – TEDCO, Maryland’s economic engine for technology companies, announced a…
Read More
MaxCyte Signs Strategic Platform License with Walking Fish Therapeutics to Support the Development of its Innovative B Cell Platform
Walking Fish to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to engineer novel B-cell based medicines for the treatment of serious diseases ROCKVILLE,…
Read More
US FDA approves GSK’s Arexvy, the world’s first respiratory syncytial virus (RSV) vaccine for older adults
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time The approval is based on…
Read More
Gain Therapeutics Awarded CHF 2.5 million Innosuisse Grant to Advance Lead Program in GBA1 Parkinson’s Disease
BETHESDA, Md., May 03, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX), a biotechnology company leading the discovery and development of allosteric small…
Read More